MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 239 filers reported holding MEDICINES CO in Q2 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $254,000 | -83.1% | 3,000 | -92.7% | 0.00% | -75.0% |
| Q2 2019 | $1,499,000 | +215.6% | 41,125 | +141.7% | 0.00% | +300.0% |
| Q1 2019 | $475,000 | +2694.1% | 17,013 | +2735.5% | 0.00% | – |
| Q3 2018 | $17,000 | -98.6% | 600 | -98.2% | 0.00% | -100.0% |
| Q3 2017 | $1,205,000 | +361.7% | 32,549 | +373.7% | 0.05% | +345.5% |
| Q2 2017 | $261,000 | -85.2% | 6,871 | -80.9% | 0.01% | -85.5% |
| Q1 2017 | $1,761,000 | +686.2% | 36,020 | +443.8% | 0.08% | +484.6% |
| Q4 2016 | $224,000 | -85.1% | 6,624 | -83.3% | 0.01% | -87.3% |
| Q3 2016 | $1,499,000 | +426.0% | 39,737 | +367.9% | 0.10% | +436.8% |
| Q2 2016 | $285,000 | +60.1% | 8,492 | +77.5% | 0.02% | +35.7% |
| Q4 2015 | $178,000 | -27.3% | 4,784 | -26.1% | 0.01% | -22.2% |
| Q3 2015 | $245,000 | -48.1% | 6,471 | -60.8% | 0.02% | -55.0% |
| Q2 2015 | $472,000 | -13.1% | 16,525 | -14.9% | 0.04% | -36.5% |
| Q1 2015 | $543,000 | +1497.1% | 19,410 | +1462.8% | 0.06% | +1475.0% |
| Q4 2014 | $34,000 | – | 1,242 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
| Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
| Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
| BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
| Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
| CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
| DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
| Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
| Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
| Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |